Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.

NASDAQ:ABEO

Overview | Financials
Company Name Abeona Therapeutics Inc.
Symbol ABEO
Currency USD
Price 5.49
Market Cap 267,911,451
Dividend Yield 0%
52-week-range 3.93 - 7.32
Industry Biotechnology
Sector Healthcare
CEO Dr. Vishwas Seshadri M.B.A., Ph.D.
Website https://www.abeonatherapeutics.com

An error occurred while fetching data.

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy

Related Stocks

Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc.

EKSO

0.413 USD

Onconova Therapeutics, Inc. logo

Onconova Therapeutics, Inc.

ONTX

0.995 USD

Landos Biopharma, Inc. logo

Landos Biopharma, Inc.

LABP

22.93 USD

Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc.

SIOX

0.478 USD

Aytu BioPharma, Inc. logo

Aytu BioPharma, Inc.

AYTU

1.213 USD

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

CLRB

0.252 USD

Financials

Numbers are in millions USD

Numbers are in millions USD